0 followers
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor... Read more
Sean P. Bohen
Kura Oncology
18 followers
SpringWorks Therapeutics
5 followers
Halozyme Therapeutics
4 followers
Stemline Therapeutics
3 followers
EyePoint Pharmaceuticals
2 followers
Aspen Neuroscience
1 follower
Biosynth
1 follower
Invaio Sciences
1 follower
Frontier Medicines
1 follower
Associates of Cape Cod, Inc.
1 follower
Scribe Therapeutics
1 follower
Explore companies